Corient Private Wealth
STIM icon

Corient Private Wealth’s Neuronetics STIM Stock Holding History

Corient Private Wealth’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,513
Closed -$117K – 2361
2023
Q4 		$117K Buy
+40,513
New +$63.9K ﹤0.01% 2145

Other funds holding STIM

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Corient Private Wealth's STIM Position: Q1 2024 in Review

Corient Private Wealth sold out of Neuronetics (STIM) in Q1 2024, closing a stake of 40,513 shares — an estimated $117K sold.

Corient Private Wealth first reported a position in STIM in Q4 2023 and held it in 1 quarter. The position peaked at $117K in Q4 2023. 66 funds tracked by Wall St. Rank hold STIM as of Q1 2024.

  • Corient Private Wealth reported no remaining Neuronetics position as of Q1 2024 after selling out during the quarter.
  • Corient Private Wealth sold 40,513 Neuronetics shares in Q1 2024, an estimated $117K.
  • Corient Private Wealth first reported a position in Neuronetics in Q4 2023 and held it in 1 quarter.
  • Corient Private Wealth's Neuronetics position peaked at $117K in Q4 2023.
  • 66 funds tracked by Wall St. Rank held Neuronetics as of Q1 2024.

Based on Corient Private Wealth's 13F filing for Q1 2024, filed 9 May 2024.